In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Webcasts - 13th Annual Meeting of the ESC Working Group on Myocardial & Pericardial Diseases

NOW Available online:

Webcasts resources from the 13th Annual Meeting
13-15 October 2016, Warnemünde - Germany

Educational courses during the 13th WG Annual meeting

Educational session 1: Diagnosis of cardiomyopathies

Chairs: A.L. Caforio, S.B. Felix


Definition and classification -an overview - Y. Pinto

Genetic testing is superior to biopsy of the myocardium in cardiomyopathy - Prof. H. Katus


Contra - H.-P. Schultheiss

Advances in imaging: echocardiography, MRI, CT and PET – what is essential for diagnostic work-up? - A. Linhart

The MOGE(S) Classification for a phenotype- genotype nomenclature of cardiomyopathy - E. Arbustini


Prognostic Relevance of gene-environment interactions in patients with dilated cardiomyopathy - S. Heymans


Educational session 2: Personalized medicine for diagnosis and treatment of myocarditis and inflammatory cardiomyopathy

Chairs: A. Anastasakis, R. Jahns

Diagnostic work up in myocarditis and DCM - M. Dörr

Endomyocardial biopsy is essential for diagnosis - C. Basso

Role of cardiovascular magnetic resonance - J. Schulz-Menger


From evidence-based treatment to future direction for research in inflammatory cardiomyopathy - U. Eriksson


Educational session 3: Hypertrophic cardiomyopathy: From bench to bedside

Chairs: P. Elliott, A. Rigopoulos

Stepwise approach for risk stratification - P. Elliott

Next generation genetic testing – What next - J. Mogensen

Gene therapy for inherited sarcomeric pediatric cardiomyopathy - L. Carrier


Evidence-based medical treatment - J. Olivotto

Evidence-based percutaneous gradient ablation - H. Seggewiss

Surgical therapies - P. Ferrazzi


Educational session 4: Myocardial involvement in systemic immune-mediated diseases: Focus on the myocardial and pericardial disease Position paper

Chairs: E. Arbustini, A. L. Caforio

Systemic autoimmune diseases and cardiac involvement: Focus on animal models and common mechanisms -V. Poli

What’s new: The cardiac pathologist’s point of view -K. Klingel

What’s new: The cardiologist’s point of view -S.B. Felix


What’s new: The immunologist’s point of view -R. Marcolongo

What next -U. Eriksson


Extra-educational session 4: The Noncoding genome in myocardial diseases – Pathogenic implications and therapeutic perspectives for the cardiomyopathies

Chairs: M. Arad, P. Charron

Noncoding RNAs in cardiovascular disease – Status of clinical translation - T. Thum

MicroRNAs in cardiac fibrosis and hypertrophy - S. Engelhardt

Monocyte-directed RNAi in cardiac inflammation - F. Leuschner


Gene editing - J.-S. Hulot

Methylome - B. Meder

Gene and microRNA based therapies for heart failure Status of clinical translation - R. Hajjar


Extra educational session 5: Diastolic and systolic dysfunction in heart failure and the cardiomyopathies   – From diagnosis to treatment

Chairs: M. Fu, A. Ristic

Immunoadsorption as a treatment option in DCM - S. B. Felix

Current evidence on treatment of patients with chronic systolic heart failure - A. Ristic

Cardiac implantable electronic devices in systolic heart failure - M. Busch


Systolic heart failure: New drugs in the pipeline - B. Pieske

New treatment options for diastolic dysfunction - G. Hasenfuß

Keynote Lecture - Myocardial regeneration in the cardio- myopathies – A therapeutic option? Basic research - T. Eschenhagen


Clinical trials - S. Janssens


Educational session 5: Rare myocardial diseases – From diagnosis to treatment

Chairs: A. L. Caforio, M. Dörr

Pediatric diseases - G. Limongelli

Anderson-Fabry disease - A. Linhart

Glycogen storage disease - M. Arad


Amyloidosis - C. Rapezzi

Neuro-muscular disease - A. Pantazis

Inflammatory cardiomyopathies - C. Basso


Keynote Lecture: Rare cardiomyopathies-challenges and opportunities - P. Elliott


Educational session 6: Diagnosis and treatment of pericardial diseases – Focus on the 2015 Guidelines

Chairs: S. Pankuweit, A. Ristic

Clinical and diagnostic work-up - B. Maisch

Medical treatment - M. Imazio

What next - Y. Adler


Educational session 7: Acute decompensated chronic heart failure – A diagnostic and therapeutic challenge in cardiomyopathies of different aetiologies

Chairs: S. Blankenberg, A. Keren

The diagnostic accuracy of the natriuretic peptides in heart   failure - J. Mant

New drugs for treatment of acute decompensated heart failure – Mitrovic

Ultrafiltration in patients with acute decompensated chronic heart failure - G. Marenzi


Impella ventricular support in patients with cardiogenic shock - M. Ferrari

Emergency extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock – D. Westermann

Keynote Lecture: Auto-immune mechanisms in myocarditis and  dilated cardiomyopathy - A. L. Caforio


Educational session 8: Arrhythmogenic cardiomyopathies

Chairs: A. Anastasakis, P. Elliott

Pathology – Still the gold standard? C. Basso

Genetic diagnosis – An update for the clinician - E. Arbustini

Clinical and non-invasive work-up - A. Tsatsopoulou


Risk stratification - T. Wichter

Keynote Lecture: Treatment of ARVC: Key messages from the international and future perspectives - D. Corrado